Prosecutors say the Van Nuys healthcare businessman controlled four Southern California hospice companies that billed Medicare for medically unnecessary, ineligible, improperly represented, or allegedly nonexistent care involving living and deceased beneficiaries
WASHINGTON, DC — Los Angeles hospice owner Oren David Shachar is accused of directing a four-company operation that submitted approximately $27.731 million in Medicare claims for care that prosecutors contend was medically unnecessary, ineligible for reimbursement, improperly represented, or procured through illegal payments.
Medicare allegedly paid approximately $26.908 million to the businesses, leaving federal prosecutors to prove that Shachar knowingly transformed separate hospice providers into a coordinated billing network rather than merely owning companies where independent clinicians, marketers, administrators, or contractors made disputed decisions.
The Justice Department account of the Southern California healthcare fraud cases identifies Gentle Touch Hospice Care, Oxford Hospice Care, Art of Hospice, and Holly Trinity Hospice as the four providers Shachar allegedly owned, controlled, or operated during relevant periods.
Shachar, Abraham Shin, and Jeannie Choi remain presumed innocent, and every allegation involving fraudulent claims, patient eligibility, services, identities, kickbacks, records, ownership, or financial proceeds must be established beyond a reasonable doubt through admissible evidence in federal court.
Four Companies Form the Alleged Operational Core
The indictment describes Gentle Touch as a Valley Glen outpatient hospice that Shachar allegedly owned, controlled, and operated beginning around February 2021, according to corporate and Medicare records cited by the grand jury within the public charging document.
Oxford operated from Montclair, and prosecutors allege that Shachar assumed ownership, control, and operational authority around December 2020, placing that provider within the business network shortly before the charged healthcare-fraud activity allegedly began during February 2021.
Art of Hospice operated from Encino, where a share-purchase agreement allegedly showed Shachar’s involvement beginning around October 2019, while a later Medicare enrollment application reportedly identified him as an owner holding at least five percent from May 2022.
Holly Trinity operated from Glendale and maintained another location in Valley Glen, with California corporate filings and Medicare records allegedly tracing Shachar’s ownership, control, and operation of that provider from approximately April 2023 onward.
Those different acquisition dates matter because prosecutors must connect company-specific records, claims, personnel, bank activity, and patients with Shachar’s alleged knowledge, while defense lawyers can examine whether authority shifted over time or remained divided among other participants.
Ownership Is Important but Does Not Decide Guilt
Corporate ownership can help establish access, authority, financial benefit, and responsibility for enrollment representations, yet ownership alone cannot prove that an individual knew a particular patient was ineligible, understood that a service record was false, or authorized an unlawful payment.
Prosecutors will therefore need evidence showing how Shachar allegedly directed daily operations across separate entities, including communications, hiring decisions, marketer relationships, clinician instructions, bank transfers, electronic-system access, patient encounters, and certifications submitted under his name.
Defense counsel may answer that physicians made independent prognosis decisions, nurses created clinical notes, marketers supplied patients, billing contractors submitted claims, and administrators managed accounts without providing Shachar complete knowledge about each transaction eventually placed inside the indictment.
The central ownership question is consequently not whether Shachar appeared within company records, because prosecutors say he did, but whether the evidence demonstrates knowing control over the fraudulent purposes and particular executions alleged by the government.
The Billing Total Requires Careful Explanation
The difference between approximately $27.731 million billed and $26.908 million paid is significant because the first number represents reimbursement requested from Medicare, whereas the second more closely describes the taxpayer money prosecutors allege the four hospices actually received.
Neither figure proves fraud without patient-level evidence, since a large aggregate can contain legitimate services, adjusted claims, reversals, administrative mistakes, contested diagnoses, and transactions whose legal character depends upon facts that cannot be resolved through totals alone.
The indictment identifies eight specific healthcare-fraud executions from August 2023 through November 2025, but prosecutors describe those claims as charged examples within a broader alleged operation whose financial reach extended across numerous beneficiaries and several years.
Jurors must evaluate each charged execution individually, ensuring that an allegation involving one hospice, beneficiary, service period, or document does not automatically establish Shachar’s knowledge and intent concerning a different claim submitted by another company.
Hospice Eligibility Depends Upon Medical Judgment
Medicare hospice generally serves beneficiaries whom physicians certify as terminally ill, commonly meaning that life expectancy is six months or less if the illness follows its normal course, after the patient knowingly elects comfort-focused rather than curative care.
Covered services can include nursing, symptom-management medication, medical equipment, counseling, social work, therapy, and support for relatives, making hospice an essential benefit whose clinical and emotional importance extends far beyond the reimbursement mechanics examined during a fraud prosecution.
Prognosis is not an exact prediction, however, and a beneficiary who improves, stabilizes, or survives longer than expected does not automatically prove that the original certification was fraudulent when a qualified professional signed it using available information.
The government must distinguish deliberate fabrication from good-faith clinical uncertainty, incomplete documentation, later disagreement, or regulatory error, while defense experts may examine diagnoses, functional status, treatment history, decline patterns, medications, examinations, and contemporaneous medical judgments.
Prosecutors Allege Some Patients Were Not Terminally Ill
According to the indictment, Shachar personally met vulnerable Medicare beneficiaries whom he allegedly knew were not terminally ill and persuaded them to enroll by portraying hospice as a program emphasizing improved daily life rather than end-of-life care.
Prosecutors further allege that Shachar and people working for him concealed the need for physician certification and failed to explain how hospice election could limit coverage for curative treatment connected with the terminal condition or affect services from other providers.
Those claims place conversations at the center of the case, requiring testimony or records showing what beneficiaries heard, what brochures and forms disclosed, whether interpreters participated, who obtained signatures, and whether patients genuinely understood the election they made.
Defense lawyers may argue that appropriate disclosures were provided, memories changed over time, complicated benefit rules caused confusion, or medical evidence reasonably supported hospice eligibility even when a patient later described the program differently to investigators.
“Not Provided as Represented” Covers Several Alleged Failures
The indictment’s language concerning services not provided as represented can encompass more than complete non-performance, because a claim may be disputed when its documented date, clinician, visit length, patient status, place of service, or medical purpose differs materially from reality.
For living beneficiaries, investigators may compare billed nursing and support services with visit notes, location information, caregiver recollections, payroll records, device data, medication deliveries, and patient conditions to determine whether claimed care occurred as documented.
For deceased beneficiaries, the dispute becomes especially stark when prosecutors allege that services were recorded before death through paperwork actually created afterward, because contemporaneous death records and electronic metadata can establish an objective chronology that clinical memory cannot easily alter.
Even then, prosecutors must attribute false entries and resulting claims to particular defendants, while the defense may distinguish permissible late documentation or routine bereavement administration from knowingly backdated records designed to obtain reimbursement for services never delivered.
Cash and Gifts Allegedly Supported Patient Retention
The indictment alleges that Shachar, personally or through marketers, offered beneficiaries as much as $400 each month to remain enrolled, creating a recurring incentive that prosecutors say connected patient participation with the hospices’ ability to continue submitting Medicare claims.
Authorities also describe groceries, alcohol, personal-care supplies, medical equipment, televisions, massages, furniture, and reclining chairs as alleged inducements, while beneficiaries were supposedly offered $100 or $200 for referring additional people who could enter the hospice network.
Assistance provided within healthcare is not inherently unlawful, because providers sometimes address genuine patient needs through carefully structured programs, but legality depends upon purpose, documentation, value, eligibility, applicable exceptions, and any relationship between assistance and federally reimbursed referrals.
The government must prove prohibited intent surrounding the identified benefits, while defense counsel can challenge whether payments occurred, whether recipients described them accurately, and whether particular items represented lawful support, reimbursement, charity, or unrelated transactions.
Marketer Compensation Allegedly Followed Monthly Billing
Prosecutors say Shachar sometimes paid marketers approximately $700 for each living beneficiary during every month that the person remained enrolled and Medicare was billed, allegedly turning patient retention into an ongoing revenue-linked compensation arrangement rather than a fixed marketing expense.
That allegation matters because compensation tied directly to referral value or reimbursement duration can suggest that clinical decisions were being influenced by financial incentives, although the government must still establish knowing and willful conduct under the applicable criminal statutes.
Bank statements, cash withdrawals, payment ledgers, messages, invoices, and insider testimony may reveal how compensation was calculated, while defense attorneys can investigate whether records were incomplete, witnesses misunderstood legitimate agreements, or prosecutors improperly characterized ordinary operational payments.
An illegal referral payment would not necessarily prove that every associated beneficiary was ineligible or received no legitimate care, requiring prosecutors to establish the elements of specific healthcare-fraud counts separately from any broader kickback theory.
Deceased Beneficiaries Introduce a Separate Alleged Pipeline
The indictment accuses Shachar of purchasing names, Social Security numbers, birth dates, Medicare identifiers, physician details, death information, and next-of-kin information belonging to deceased beneficiaries from alleged marketers Shin and Choi during 2025.
Choi allegedly obtained sensitive information through employment at an unnamed California-licensed funeral business, after which photographs of documents and accompanying details were transmitted through text messages and WhatsApp conversations for use within the alleged hospice activity.
Prosecutors say surviving relatives were then contacted for personal health information, recent hospital records were requested, and signatures connected with hospice enrollment were gathered after the people named in the documents had already died.
The allegations require careful proof concerning data access, device ownership, account attribution, representative authority, signature timing, and each participant’s knowledge, because possession of medical information within a healthcare setting does not automatically establish unauthorized or criminal use.
Backdated Records Allegedly Made Care Appear Real
Federal prosecutors allege that Shachar directed a nurse, a physician, and others to create false electronic records stating that deceased beneficiaries had been evaluated while alive and certified as terminally ill before supposed hospice services were provided.
Electronic medical platforms can preserve creation times, edit histories, signatures, user accounts, imported documents, and billing exports, allowing specialists to compare the official narrative with death certificates, hospital records, communications, payroll activity, and claim submission dates.
Defense experts may challenge inaccurate system clocks, software migrations, shared credentials, delayed synchronization, copied templates, audit-log limitations, or assumptions that a user account conclusively identifies the person who created, reviewed, understood, or approved an entry.
The persuasive strength of digital evidence will depend upon whether independent sources converge upon the same chronology, rather than whether prosecutors can merely display suspicious timestamps without reliably explaining how the underlying systems generated and preserved them.
Alleged Selection Rules Suggest an Effort to Avoid Scrutiny
Prosecutors claim Shachar imposed rules requiring deceased referrals to involve people who died at home, died within five days of a marketer’s contact, and were not already receiving hospice from another provider when death occurred.
The government alleges those conditions were designed to reduce detection, conceal an unusually high rate of patients leaving hospice alive, and offset Medicare’s annual per-beneficiary spending limit by adding purported patients whose deaths appeared consistent with genuine terminal eligibility.
Shachar allegedly paid between $1,000 and $3,000 for each deceased beneficiary enrolled, while insisting that the funeral business preserve accurate death times so hospice records and meetings with surviving relatives could be arranged around those facts.
These accusations remain unproven, and defense counsel may dispute whether any selection rule existed, who created it, how statements were interpreted, whether post-death administration had lawful purposes, and whether Shachar authorized false documentation or billing.
The Four-Company Structure Could Complicate Detection
Operating multiple providers can create legitimate efficiencies through shared expertise, staffing, purchasing, compliance systems, and regional coverage, but it can also fragment billing patterns so concerning activity appears smaller when regulators examine each enrollment number separately.
Investigators will likely ask whether beneficiaries, clinicians, marketers, addresses, bank accounts, telephone numbers, ownership interests, and electronic records moved among Shachar’s companies in ways that reveal centralized control or efforts to distribute suspicious indicators.
The defense can argue that shared resources are ordinary within related healthcare organizations, especially when professionals serve multiple locations, and that operational overlap does not establish fraud unless specific evidence connects the arrangement with materially false claims.
Effective oversight must therefore examine common ownership and recurring relationships without treating every affiliated provider network as criminal, because legitimate consolidation and unlawful coordination can produce superficially similar corporate patterns while reflecting fundamentally different purposes.
Enrollment Applications Could Demonstrate Knowledge of the Rules
The indictment alleges that Shachar submitted at least eleven Medicare enrollment applications certifying that the hospices would claim only medically necessary services provided as represented and would comply with restrictions against kickbacks and bribes connected with beneficiary referrals.
Prosecutors may use those certifications to argue that Shachar understood the rules before the disputed conduct occurred, particularly if later communications demonstrate that he directed practices conflicting with representations personally made to secure or maintain billing privileges.
Defense lawyers can respond that broad compliance attestations do not prove knowledge about every later claim, patient, employee, or payment, especially when complex businesses delegate clinical judgments, intake functions, coding, documentation, and financial administration among specialized personnel.
The significance of each application will ultimately depend upon its date, contents, signer, supporting records, and relationship with charged transactions, ensuring that a general promise does not substitute for proof of intentional deception involving identified Medicare claims.
Money Flow May Reveal How the Businesses Were Connected
Financial records can show whether Medicare reimbursements remained within each hospice for payroll, equipment, medication, and patient services or moved among related companies, owners, marketers, personal accounts, and high-value purchases without a documented operational purpose.
Count Thirteen alleges that Shachar caused $15,000 from a Holly Trinity account to fund part of a lease-to-own down payment for a Rolls-Royce Phantom, which prosecutors characterize as a transaction involving property derived from healthcare fraud.
Luxury spending can attract attention and strengthen a narrative about motive, but it cannot replace financial tracing that connects the transferred money with qualifying criminal proceeds while also proving the defendant possessed the knowledge required by federal law.
Defense attorneys may identify lawful revenue inside commingled accounts, question the tracing methodology, dispute Shachar’s knowledge, or argue that the vehicle payment lacked the statutory relationship with proven fraud necessary for conviction on the financial count.
The National Crackdown Magnified a Local Case
The Shachar prosecution emerged during a nationwide healthcare fraud takedown involving approximately 455 defendants and more than $6.5 billion in alleged schemes, giving the Los Angeles hospice accusations an immediate national audience beyond their Central District courtroom.
Wall Street Journal reporting on the federal healthcare fraud crackdown placed Shachar’s case within an expanded enforcement campaign using interagency data sharing and analytics to identify suspicious claims, relationships, and financial patterns across public benefit programs.
National totals and unrelated prosecutions cannot prove anything against Shachar, Shin, or Choi, however, because jurors must decide their case from admissible evidence concerning the named companies, beneficiaries, payments, records, and communications rather than enforcement publicity.
The FBI and the inspector general’s office within the Department of Health and Human Services are investigating, while federal fraud prosecutors carry the burden of converting the indictment’s detailed narrative into reliable, count-specific proof at trial.
Patients May Experience Harm Beyond Financial Loss
If an ineligible person is enrolled through deception, the consequences can extend beyond government reimbursement because hospice election may affect curative treatment coverage, disrupt relationships with established physicians, expose private records, and confuse families about a beneficiary’s actual medical condition.
When care is billed but not delivered as represented, patients may miss nursing attention, symptom management, equipment, counseling, or support they reasonably expected, while inaccurate records can follow them into later treatment and distort future medical decisions.
The alleged use of deceased identities creates another injury by transforming intimate medical histories and grieving relatives into components of a billing process, potentially requiring families to revisit painful events through interviews, subpoenas, document review, and testimony.
Legitimate hospice providers also suffer when dramatic fraud allegations weaken public confidence, making precise reporting essential so readers distinguish the charged conduct of particular defendants from compassionate end-of-life care delivered lawfully throughout the country.
Compliance Programs Must See Across Related Entities
Owners controlling multiple hospices should receive consolidated reports identifying patient overlap, shared personnel, marketer activity, live discharges, lengths of stay, visit frequency, claim denials, late documentation, beneficiary complaints, ownership changes, and unusual access to medical records.
Each provider should preserve original certifications, document the clinical basis for eligibility, verify representative authority, disclose late entries, reconcile service notes with claims, and prevent billing when required records remain incomplete, inconsistent, or unsupported.
Access controls should prohibit shared credentials, restrict bulk downloads, flag records opened after death without an approved purpose, preserve metadata, and promptly deactivate employees, contractors, clinicians, or marketers who no longer require protected information.
Financial safeguards should distinguish payroll, reimbursements, charitable assistance, marketing costs, referral compensation, loans, owner distributions, intercompany transfers, and personal purchases, allowing auditors to understand transactions through contemporaneous evidence rather than explanations created after scrutiny begins.
Reputation Damage Arrives Before a Verdict
An accusation combining deceased beneficiaries, cash inducements, identity misuse, false medical records, four companies, and a Rolls-Royce can dominate search results immediately, affecting banking relationships, employees, families, referrals, licensing attention, and community trust before defense evidence becomes public.
Amicus International Consulting’s framework for crisis public-relations planning during serious allegations emphasizes disciplined assessment and controlled communication, although any response to an active healthcare prosecution must preserve evidence, protect patient privacy, avoid witness influence, and remain coordinated with qualified legal counsel.
A responsible public statement can acknowledge the indictment, affirm the presumption of innocence, explain verified procedural developments, and correct demonstrable reporting errors without attacking beneficiaries, revealing confidential records, manufacturing support, or promising a result that nobody can guarantee.
Longer-term reputation rebuilding after damaging publicity requires accurate visibility for dismissals, pleas, verdicts, sentencing findings, compliance reforms, and appeals, ensuring that the original accusation does not remain the only discoverable account after the public record materially changes.
The Defense Can Challenge Every Operational Link
Shachar’s lawyers may contest patient eligibility, disclosure practices, signature authenticity, physician independence, document timing, electronic attribution, marketer credibility, payment purpose, company control, claim submission, financial tracing, and whether administrative failures were improperly transformed into allegations of intentional fraud.
Insider witnesses may describe instructions and recurring methods, but cross-examination can explore cooperation benefits, personal criminal exposure, employment disputes, inconsistent statements, financial motives, memory limitations, and whether each witness directly observed the conduct attributed to Shachar.
Medical experts may disagree about terminal prognosis, digital specialists may interpret audit logs differently, and accountants may dispute tracing assumptions, leaving jurors responsible for deciding whether the government’s separate sources reinforce one another beyond a reasonable doubt.
Reasonable doubt does not require one explanation covering the entire alleged operation, because evidence may be persuasive for one company, beneficiary, or payment while remaining incomplete, unreliable, or legally insufficient for another charged transaction.
An Indictment Remains an Accusation
A grand jury’s indictment determines that probable cause supports charges, but it does not resolve guilt through the adversarial process where defense lawyers test witnesses, challenge exhibits, present lawful evidence, and require prosecutors to satisfy demanding criminal standards.
The government must prove more than suspicious ownership, inadequate paperwork, unusual spending, regulatory violations, or poor management, because the charged offenses require specific combinations of fraudulent intent, material deception, unauthorized identity use, unlawful remuneration, agreement, and financial knowledge.
Shin and Choi face allegations connected with narrower periods and activities than Shachar, meaning evidence admissible against one defendant may not establish another participant’s knowledge, and their legal strategies could diverge as the case progresses.
Until a valid guilty plea, dismissal, or verdict changes the legal posture, all three defendants retain the presumption of innocence and the right to require proof concerning every individual count rather than one generalized allegation about the industry.
The Case Tests Whether Corporate Control Can Be Proven as Criminal Direction
Prosecutors portray Shachar as the organizing owner who linked four hospices, patient recruitment, financial inducements, sensitive identifiers, clinical records, Medicare billing, and personal spending within one alleged operation producing nearly $27.7 million in claims.
The defense will likely seek to separate those components, demonstrating where doctors, nurses, marketers, administrators, relatives, billing personnel, or other owners acted independently and where the government’s theory relies upon inference rather than direct proof.
The outcome will depend upon patient-specific medicine, authenticated communications, reliable metadata, corporate documents, credible witnesses, and careful financial analysis, not simply the prominence of the billing total or the emotional power of allegations involving deceased people.
As federal proceedings continue, the Los Angeles case will remain both a courtroom test of individual responsibility and a broader warning that multi-company hospice ownership demands transparent clinical governance, auditable payments, secure records, and measurable delivery of promised care.
